Xavo, a provider of software solutions for Life Sciences R&D, has announced Plexium as its latest client.

“We are thrilled to welcome Plexium to the Xavo family. The collaboration between the two companies marks a significant milestone in Xavo’s journey. We stay committed to deliver cutting-edge technology, tailored to meet the evolving needs of R&D labs worldwide,” said Gabriel Petrescu, Xavo’s VP of Business Development.

Plexium, Inc., a biopharmaceutical company based in San Diego, CA, specializes in next-generation targeted protein degradation modalities for the treatment of cancer, neurodegeneration, and other diseases.

“I was on a tight timeline when searching for a new sample management software partner,” recalled Nicole Anderson, Head of Compound Management at Plexium. “I was impressed by the caliber of the Xavo team and their excitement about the recent innovations in their software. Since launching Xavo, even complex workflows execute efficiently.”

Leveraging Xavo’s rapid deployment capabilities, out-of-the-box product functionality, and preconfigured integrations, the joint team successfully launched the sample management platform quickly.

“The successful deployment at Plexium demonstrates the maturity of our product and the agility of our processes,” said Florian Tauchert, Xavo’s Managing Director.